$271Million– No. of Holdings #9
| Ticker | $ Bought |
|---|---|
| eikon therapeutics, inc. | 13,954,800 |
| pharvaris n.v. | 5,484,030 |
| nurix therapeutics, inc. | 4,107,500 |
| Ticker | % Inc. |
|---|---|
| hims & hers health, inc. | 170 |
| disc medicine, inc. | 25.08 |
| alumis inc. | 2.04 |
| Ticker | % Reduced |
|---|---|
| maze therapeutics, inc. | -69.98 |
| Ticker | $ Sold |
|---|---|
| natera, inc. | -15,430,600 |
Foresite Capital Management V, LLC has about 89.3% of it's holdings in Others sector.
| Sector | % |
|---|---|
| Others | 89.3 |
| Consumer Defensive | 5.7 |
| Healthcare | 5 |
Foresite Capital Management V, LLC has about 0% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| UNALLOCATED | 89.3 |
| MID-CAP | 5.7 |
| SMALL-CAP | 5 |
About 10.7% of the stocks held by Foresite Capital Management V, LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| Others | 89.3 |
| RUSSELL 2000 | 10.7 |
This heatmap illustrates the top 50 positions within the fund's portfolio.
Foresite Capital Management V, LLC has 9 stocks in it's portfolio. HIMS proved to be the most loss making stock for the portfolio. was the most profitable stock for Foresite Capital Management V, LLC last quarter.
Last Reported on: 15 May, 2026| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| HIMS | hims & hers health, inc. | 5.66 | 738,151 | 15,324,000 | added | 170 | ||
| LYEL | lyell immunopharma, inc. | 3.53 | 477,078 | 9,570,180 | unchanged | 0.00 | ||
| NRIX | nurix therapeutics, inc. | 1.52 | 265,000 | 4,107,500 | new | |||
| NTRA | natera, inc. | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| PHVS | pharvaris n.v. | 2.02 | 194,125 | 5,484,030 | new | |||
| alumis inc. | 47.94 | 5,897,000 | 129,911,000 | added | 2.04 | |||
| cg oncology, inc. | 25.08 | 1,004,050 | 67,954,100 | unchanged | 0.00 | |||
| disc medicine, inc. | 8.83 | 374,069 | 23,918,000 | added | 25.08 | |||
| eikon therapeutics, inc. | 5.15 | 1,318,980 | 13,954,800 | new | ||||
| maze therapeutics, inc. | 0.28 | 25,905 | 773,264 | reduced | -69.98 | |||